Key drugs Repatha, Aimovig flail as cheap copies eat into Amgen sales 0 01.05.2019 03:00 Fiercepharma.com As copycats eat into Amgen’s older products, the Big Biotech is looking to its newer launches to stem the tide. But some of them are not getting it done. Moscow.media Частные объявления сегодня Rss.plus Все новости за 24 часа
